Vaccines & Vaccination

Biography

Mohamed L. Salem (PhD, 1995) is the Professor of Immunology at Tanta University, Egypt and Visiting Professor at Hollings Cancer Center and Department of Microbiology and Immunology, Medical University of South Carolina, USA. Dr. Salem is the Director of Delta Development Research Center which is a regional branch of Academy of Scientific Research and Technology (ASRT), Egypt; Director of the Grant, Innovation & Technology Transfer Center, and Founder and Director of Center of Excellence in Cancer Research, Tanta University, Egypt. Dr. Salem obtained his PhD in 1995 through a channel system between Tanta University, Egypt and Kyushu University, Japan. From 1997 -2001, he was a Postdoctoral Fellow at Kyushu University, Japan and from 2002-2010 as an Assistant Professor at Medical University of South Carolina, USA. Dr. Salem is member of the National Committee for Professorship Promotion (Zoology) and Member of the National Committee for the Biological Sciences (ASRT). He is also a founder member of the Egyptian Association of Cancer Research and Middle Eastern Association for Cancer Research, Canada. Dr Salem won the State Incentive Award in 2003 and the State Excellent Award in 2009 in Basic Sciences from the Academy of Scientific Research and Technology, Egypt based on his research on cancer immunotherapy. His h-index is 24 and published about 111 articles in peer-reviewed journals and attended more than 70 national and international workshops and conferences in Immunology. He supervised more than 55 Master and PhD students. He is a member of several editorial boards of peer-reviewed journals as well as ad hoc reviewer for more than 80 journals. He has been invited to give talks in cancer immunotherapy in Egypt, UAE, Jordan, Saudi Arabia, USA, and Canada. Dr Salem’s research focuses on understanding the cellular and molecular mechanisms underlying how cancer and HCV escape from host immunity, in particular the rules of immunoregulatory cells including lymphoid and myeloid lineages. Additionally his research has been focusing on developing effective anticancer immunotherapies strategies, in particular the use of adoptive cell therapy. His research projects have been funded by National Institute of Health, USA, Science and Technology Development Fund (STDF), Egypt, USA National Academy of Sciences, Tanta University, Egypt, private foundation and industry.

Research Interest

Dr Salem’s research focuses on understanding the cellular and molecular mechanisms underlying how cancer and HCV escape from host immunity, in particular the rules of immunoregulatory cells including lymphoid and myeloid lineages. Additionally his research has been focusing on developing effective anticancer immunotherapies strategies, in particular the use of adoptive cell therapy. His research projects have been funded by National Institute of Health, USA, Science and Technology Development Fund (STDF), Egypt, USA National Academy of Sciences, Tanta University, Egypt, private foundation and industry.